(19)
(11) EP 1 740 100 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.01.2017 Bulletin 2017/04

(45) Mention of the grant of the patent:
12.10.2016 Bulletin 2016/41

(21) Application number: 05712902.5

(22) Date of filing: 04.02.2005
(51) International Patent Classification (IPC): 
A61B 10/00(2006.01)
A61B 8/00(2006.01)
C09B 11/24(2006.01)
A61B 5/00(2006.01)
C09B 11/08(2006.01)
G01N 33/58(2006.01)
(86) International application number:
PCT/US2005/003627
(87) International publication number:
WO 2005/102176 (03.11.2005 Gazette 2005/44)

(54)

XANTHENE DYES

XANTHEN-FARBSTOFFE

COLORANTS AU XANTHENE


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 13.04.2004 US 824175

(43) Date of publication of application:
10.01.2007 Bulletin 2007/02

(73) Proprietor: Biosearch Technologies, Inc.
Petaluma, CA 94954 (US)

(72) Inventors:
  • REDDINGTON, Mark
    San Francisco, CA 94129 (US)
  • LYTTLE, Matt
    San Rafael, CA 94901 (US)

(74) Representative: HGF Limited 
1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)


(56) References cited: : 
EP-A- 0 805 190
WO-A-97/39064
WO-A-03/028724
US-A- 4 329 461
US-A- 6 080 852
WO-A-00/64988
WO-A-02/055512
WO-A-2005/085470
US-A- 4 647 675
   
  • K.SLAIS ET AL.: "Fluorescein-based p/ markers for capillary isoelectric focusing with lase-induced fluorescence detection" ELECTROPHORESIS, vol. 23, 2002, pages 1682-1688, XP002539290
  • L.CRESPO ET AL.: "Peptide Dendrimers based on Polyproline Helices" J.AM.CHEM.SOC., vol. 124, 2002, pages 8876-8883, XP009120789
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).